Serge Saxonov, 10x Genomics CEO

Ex­clu­sive: 10x Ge­nomics CEO touts ‘in­cred­i­ble trac­tion’ with newest launch, ship­ping over 100 spa­tial bi­ol­o­gy an­a­lyz­ers

10x Ge­nomics has seen “in­cred­i­ble trac­tion” with its newest prod­uct, Xe­ni­um, ship­ping over 100 an­a­lyz­ers since launch­ing less than a year ago, CEO Serge Sax­onov told End­points News.

The mile­stone, an­nounced Tues­day, is the lat­est sign of speedy adop­tion in re­searchers us­ing new spa­tial bi­ol­o­gy tools to peer in­side of cells. Xe­ni­um acts like a mol­e­c­u­lar mi­cro­scope, Sax­onov said, vi­su­al­iz­ing how mol­e­cules are or­ga­nized in­side a tis­sue sam­ple. Since launch­ing last De­cem­ber, 10x’s newest in­stru­ment has out­per­formed the com­pa­ny and Wall Street’s ex­pec­ta­tions.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.